The Food and Drug Administration has failed to ensure that drugs given prized rare-disease status meet the intent of a 35-year-old law, federal officials revealed in a report Friday.
All news from General Medicine
A targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS. Regorafenib (Stivarga) is to be offered to people with advanced liver cancer in England and Wales who can't have surgery and have already been treated with another drug called sorafenib (Nexavar).
Medicare says its proposal will give Part D drug plans more power to negotiate with pharmaceutical companies, but some patient and provider groups say that it will reduce access and shift costs onto beneficiaries.
Our bodies contain two types of fat: white fat and brown fat. While white fat stores calories, brown fat burns energy and could help us lose weight. Now, scientists at the University of Cambridge have found a way of making the white fat 'browner' and increasing the efficiency of brown fat.
A new paper published by McGill University researchers in JAMA Internal Medicine suggests that some clinical trials may promote the use of ineffective and costly treatments. That's the opposite of what clinical trials are aimed at, namely preventing ineffective and costly treatments from being taken up by physicians and patients.
The US Food and Drug Administration (FDA) has sent warning letters to two companies illegally marketing dietary supplements containing the unapproved antidepressant tianeptine (Stablon, Serdia Pharmaceuticals), which the companies claim can relieve opioid addiction, pain, and anxiety.
Coverage for adult obesity treatments has risen considerably in the past decade among US Medicaid and state employee insurance programs, but there is wide state-to-state variation and recommended therapies still aren't covered in many states, new research has found.
Eating leafy greens, dark orange, and red vegetables and berry fruits, and drinking orange juice may be associated with a lower risk of memory loss over time in men, according to a study published in the November 21, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
The US Food and Drug Administration (FDA) has approved the antibacterial agent rifamycin delayed-release tablets (Aemcolo, Cosmo Technologies) to treat adults with travelers’ diarrhea caused by noninvasive strains of Escherichia coli not complicated by fever or blood in the stool.
Pharmacists are pivotal in the process of deprescribing risky medications in seniors, leading many to stop taking unnecessary sleeping pills, anti-inflammatories and other drugs, a new Canadian study has found.